Switch theme
Sign up to access all valuation multiples
Attendo AB is a company that is engaged in providing private care and healthcare services in the Nordics. It focuses on offering care for older people, care for people with disabilities, individual and family care, and health care. The company also offers health, medical, and as well as staffing services. Geographically, the group's majority revenue is generated from Finland.
1985
21.5K+
LTM Revenue $1.9B
LTM EBITDA $346M
$2.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Attendo has a last 12-month revenue of $1.9B and a last 12-month EBITDA of $346M.
In the most recent fiscal year, Attendo achieved revenue of $1.9B and an EBITDA of $342M.
Attendo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Attendo valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $1.7B | $1.9B | XXX | XXX | XXX |
| Gross Profit | $383M | $502M | XXX | XXX | XXX |
| Gross Margin | 22% | 27% | XXX | XXX | XXX |
| EBITDA | $303M | $342M | XXX | XXX | XXX |
| EBITDA Margin | 18% | 18% | XXX | XXX | XXX |
| Net Profit | $4.5M | $37.3M | XXX | XXX | XXX |
| Net Margin | 0% | 2% | XXX | XXX | XXX |
| Net Debt | $181M | $114M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Attendo's stock price is SEK 60 (or $6).
Attendo has current market cap of SEK 9.1B (or $902M), and EV of SEK 25.0B (or $2.5B).
See Attendo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.5B | $902M | XXX | XXX | XXX | XXX | $0.37 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Attendo has market cap of $902M and EV of $2.5B.
Attendo's trades at 1.3x LTM EV/Revenue multiple, and 7.2x LTM EBITDA.
Analysts estimate Attendo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Attendo and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $2.5B | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 7.3x | XXX | XXX | XXX |
| P/E | 20.2x | XXX | XXX | XXX |
| P/E/Growth | 1.2x | XXX | XXX | XXX |
| EV/FCF | 11.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAttendo's NTM/LTM revenue growth is 2%
Attendo's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $31K for the same period.
Over next 12 months, Attendo's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Attendo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Attendo and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 21% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $31K | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 36% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Attendo acquired XXX companies to date.
Last acquisition by Attendo was XXXXXXXX, XXXXX XXXXX XXXXXX . Attendo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Attendo founded? | Attendo was founded in 1985. |
| Where is Attendo headquartered? | Attendo is headquartered in Sweden. |
| How many employees does Attendo have? | As of today, Attendo has 21.5K+ employees. |
| Who is the CEO of Attendo? | Attendo's CEO is Mr. Martin Tiveus. |
| Is Attendo publicy listed? | Yes, Attendo is a public company listed on STO. |
| What is the stock symbol of Attendo? | Attendo trades under ATT ticker. |
| When did Attendo go public? | Attendo went public in 2015. |
| Who are competitors of Attendo? | Similar companies to Attendo include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of Attendo? | Attendo's current market cap is $902M |
| What is the current revenue of Attendo? | Attendo's last 12-month revenue is $1.9B. |
| What is the current EBITDA of Attendo? | Attendo's last 12-month EBITDA is $346M. |
| What is the current EV/Revenue multiple of Attendo? | Current revenue multiple of Attendo is 1.3x. |
| What is the current EV/EBITDA multiple of Attendo? | Current EBITDA multiple of Attendo is 7.2x. |
| What is the current revenue growth of Attendo? | Attendo revenue growth between 2023 and 2024 was 10%. |
| Is Attendo profitable? | Yes, Attendo is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
